INTRODUCTION
increase their core temperature by seeking external sources of heat during infections, 1 indicating that it arose approximately 600 millions years ago. The persistence of fever for over 600 million years despite its considerable metabolic cost offers persuasive evidence that it is protective in the infected host, an assumption that is well supported by studies in diverse animal species (reviewed by Hasday and Singh 2 ).
Exposure to elevated temperatures has been shown to modify certain components of innate immune defenses (reviewed by Hasday and Singh 2 ), including regulation of the pro-inflammatory cytokines interleukin (IL)-1 and tumor necrosis factor (TNF)-α. [3] [4] [5] [6] [7] In our own laboratory, we showed that continuous exposure to FRT (38.5-40°C) beginning 30 min prior to cell activation is sufficient to attenuate TNF-α and IL-1β expression in human monocytes and monocyte-derived macrophages, 4,5 mouse peritoneal macrophages, 6 mouse Kupffer cells, 8 and human THP-1 5 and mouse RAW 264.7 6, 7, 9 macrophage cell lines in vitro. We showed that the reduction in TNF-α expression in RAW 264.7 cells and in mouse peritoneal macrophages exposed to FRT was predominantly caused by a marked reduction in the duration of transcriptional activation. 6 Recent studies have identified heat shock factor (HSF)-1, the predominant heat/stress-stimulated transcriptional activator of HSP genes, 10 as a repressor of TNF-α 6, 7 and IL-1β 11 as well as c-fos 12 and urokinase 12 genes. HSF-1 appears to be capable of repressing transcription via multiple distinct mechanisms. HSF-1 represses activation of the IL-1β gene by binding to a cognate binding sequence (heat shock response element; HRE) contiguous with the binding site for the C/EBPβ/NF-IL6 transcriptional enhancer and preventing its access to the IL-1β promoter. 11 More recently, Xie et al. 13 have reported that HSF-1 also directly interacts with NF-IL6 and that the two transcription factors are mutually antagonistic. In the case of c-fos, the retention of repressor activity by DNA binding-and transactivationdeficient HSF-1 mutants and the absence of an HRE in the c-fos promoter indicate that HSF-1 represses c-fos and IL-1β through different molecular mechanisms that do not require its binding to DNA. 12 We identified a nearly canonical HRE (AGAACATCTT) in the 5′ untranslated region (UTR) of the murine TNF-α gene located 50 nt downstream of the transcription start site. Using EMSA analysis, we found that HSF-1 was activated to a DNA binding form in RAW 264.7 cells incubated at 39.5°C 6 and bound both the canonical HRE from the human HSP70 promoter and the proximal TNF-α promoter/5′-UTR sequence in vitro. Chromatin immunoprecipitation (ChIP) analysis confirmed that HSF-1 binds to both the endogenous TNF-α and HSP70 genes in vivo in RAW 264.7 cells exposed to 39.5°C. 7 However, the HSF-1 in the 39.5°C RAW 264.7 cultures failed to activate HSP gene expression. 6 Transient overexpression of HSF-1 inhibited reporter genes driven by either a minimal 85 nt TNF-α promoter/5′-UTR fragment or a full-length 1.1 kb promoter/5′-UTR TNF-α gene fragment. Mutational inactivation of the HRE-like sequence in the TNF-α 5′-UTR abrogated HSF-1 binding to the minimal promoter/5′-UTR sequence and blocked HSF-1-mediated repression of a reporter plasmid driven by this TNF-α gene fragment. 7 However, the same 5′-UTR mutation had no effect on HSF-1-induced repression of the fulllength TNF-α promoter. Furthermore, EMSA analysis using upstream TNF-α sequences as probes revealed the presence of multiple high affinity HSF-1 binding sites throughout this region. Collectively, these results suggest the presence of redundant HSF-1-dependent repressor elements in the TNF-α 5′ flanking sequence.
Because HSF-1 is activated by FRT to a DNA-binding trans-repressor of TNF-α and the TNF-α 5′ flanking sequence contains multiple HSF-1-dependent repressors, we asked how TNF-α transcription could occur at all in the presence of HSF-1. In the present study, we test the hypothesis that macrophage activation triggers a transient inactivation of HSF-1 repression that is temporally associated with TNF-α transcription. Electrophoretic mobility shift assays (EMSA) revealed that LPS triggers a transient loss of active HSF-1 in RAW 264.7 cells pre-incubated at 39.5°C, which temporally correlated with TNF-α transcriptional activation. HSF-1 inactivation was associated with an apparent small and transient increase in HSF-1 molecular weight and decrease in its pI and appearance of HSF-1 phosphorylating activity, suggesting that LPSinduced phosphorylation of HSF-1 might lead to its loss of repressor activity. We show that treating cells with the serine/threonine phosphatase inhibitor, calyculin A, abrogated the inhibition of TNF-α generation in 39.5°C RAW 264.7 cell culture and prevented the re-activation of HSF-1 that usually occurs 60 min after LPS stimulation. Based on these observations, we propose that macrophages exposed to FRT accumulate a pool of repressor HSF-1. LPS treatment stimulates a sequential phosphorylation and dephosphorylation of HSF-1, causing a cycle of inactivation and re-activation of HSF-1 repressor activity that allows a temporally-limited period of gene transcription. The net effect is to change the pattern of TNF-α and IL-1β expression to short pulses rather than prolonged expression.
MATERIALS AND METHODS

Cell culture
The RAW 264.7 mouse macrophage cell line was purchased from the American Type Cell Collection (ATCC; Manassas, VA, USA) and maintained in RPMI 1640 supplemented with 50 U/ml penicillin, 50 µg/ml streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES buffer (Gibco/Invitrogen, Carlsbad, CA, USA), pH 7.3 (CRPMI) and containing 10% defined fetal bovine serum (FBS; Hyclone, Logan, UT, USA) at 37°C in 5% CO 2 -enriched air. Cells were routinely tested for Mycoplasma infection using a commercial assay system (MycoTest; Gibco/Invitrogen) and new cultures were established monthly from frozen stocks. All media and reagents contained less than 0.1 ng/ml endotoxin as determined by Limulus amebocyte lysate assay (Associates of Cape Cod; Falmouth, MA, USA). Cell viability was determined by trypan blue dye exclusion. Cells were stimulated with LPS that was prepared by trichloroacetic acid precipitation from Escherichia coli O111:B4 (Difco, Detroit, MI, USA). Cell viability was assessed by the reduction of [3-(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) using Promega's CellTiter 96 ® AQueous Non-Radioactive Cell Proliferation Assay, performed as described in the manufacturer's protocol.
EMSA
RAW 264.7 cells were lysed in buffer C according to Schreiber et al. 14 containing 10 mM HEPES pH 7.9, 420 mM NaCl, 1 mM EGTA, 1 mM DTT and protease inhibitors and total protein was measured using a commercial reagent (Bio-Rad, Hercules, CA, USA) with bovine serum albumin as standard. Double-stranded oligonucleotide containing the heat shock response element (HRE) corresponding to -107/-83 of the human HSP-70 promoter 15 5′-GATCTCGGCTGGAATATTCCCGACCTG-GCAGCCGA-3′ and the complementary strands were synthesized, annealed, and radiolabeled using T4 polynucleotide kinase (Promega; Madison, WI, USA) and [γ-32 P]-ATP according to the manufacturer's protocol. EMSA reactions containing 5 µg cell extract, 0.04 pmole radiolabeled HRE probe, 1 µg poly-dI/dC, 10 mM Tris-HCl pH 7.8, 10% glycerol, 60 mM NaCl, 1 mM EDTA, and 1 mM DTT in 20 µl were incubated at room temperature for 30 min. Where indicated, excess unlabeled competitor doublestranded oligonucleotide or 1 µl of anti-HSF-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were incubated with the nuclear extracts for 30 min at room temperature before the addition of the radiolabeled probe. The DNA-protein complexes were then electrophoretically resolved on 4% non-denaturing polyacrylamide gels. The dried gels were analyzed by phosphorimaging (Molecular Dynamics) and subsequently exposed to X-ray film.
Immunoblotting
Cell extracts were prepared in RIPA buffer containing 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitors (inhibitor cocktail, Boehringer, Indianapolis, IN, USA), 50 mM NaF, 20 mM β-glycerophosphate, 1 mM sodium vanadate, 2 nM calyculin A and 10 nM okadaic acid. For immunoblotting, 20 µg total protein was separated by 7.5% SDS-PAGE, electrostatically transferred to polyvinylidene difluoride membrane (Stratagene), blocked with 5% non-fat dry milk in 25 mM Tris (pH 7.4), 0.5 M NaCl/0.05% (v/v) Tween-20 for 30 min at room temperature, and incubated with 1:5000 dilution of anti-HSF-1 antibody (Santa Cruz Biotechnology) in blocking buffer for 1 h. Bands were detected using a 1:5000 dilution of goat anti-rabbit IgG horseradish peroxidase conjugate (Biorad) in blocking buffer for 30 min at room temperature, developed with a chemiluminescence detection system (Renaissance™; New England Nuclear, Boston, MA, USA), and exposed to X-ray film.
Immunoprecipitation and 2-dimensional electrophoresis
Cells were lysed in RIPA lysis buffer containing 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitors (complete mini tablets, Boehringer), 50 mM NaF, 20 mM β-glycerophosphate, 1 mM sodium vanadate, 2 nM calyculin A and 10 nM okadaic acid. About 500 µg of protein from cell extracts was precleared with Protein A/G agarose for 1 h, incubated with anti-HSF-1 antibody (Neomarkers, Fremont, CA, USA) for 4 h at 4°C followed by overnight incubation with Protein A/G agarose at 4°C. The immunoprecipitate was washed and resuspended in 2-D sample buffer from Proteome Systems (Woburn, MA, USA) and centrifuged at 10,000 g for 10 min. The resultant supernatant was resolved on the first dimension overnight using an 11 cm immobilized pH 3-10 gradient strip (Proteome Systems) for a total of 75,000 V-h at 20°C . The strip was equilibrated with IPG equilibration buffer (Proteome Systems) and then run in the second dimension using a 6-15% gradient gel (Proteome Systems). The resolved proteins were transferred to PVDF membranes and immunoblotted with anti-HSF-1 antibody from Santa Cruz Biotechnology.
In vitro kinase assay
Cells were lysed in kinase lysis buffer containing 20 mM Tris-HCl, (pH 8.0), 5 mM MgCl 2 , 10 mM EGTA, 1% Triton X-100, 50 mM NaF, 100 µM sodium vanadate, 2 nM calyculin A, 10 nM okadaic acid and protease inhibitors (1 tablet complete mini per 10 ml, Boehringer). Following lysis, the extracts were centrifuged for 10 min at 4°C and the supernatant was used for kinase assays. Kinase assays were performed in 100 µl reaction volume Bacterial endotoxin modifies heat shock factor-1 activity in RAW 264.7 cells 177 using 50 µg cell lysates in kinase assay buffer containing 40 mM HEPES, (pH 8.0), 1 mM DTT, 20 mM MgCl 2 , 0.1 mM EGTA, and 100 µM sodium vanadate, 30 µM ATP, 10 µCi/ml of [γ-32 P]-ATP and 2.5 µg recombinant HSF-1 as substrate. The reaction mix was incubated for 30 min at 32°C and resolved by SDS-PAGE. The gels were dried and exposed. Recombinant human HSF-1 was generated from a glutathione S-transferase-human HSF-1 fusion construct in pGEX 2T (Amersham Pharmacia, Piscataway, NJ, USA) and purified over a glutathione Sepharose 4B column (Amersham Pharmacia) according to the manufacturer's instructions as we have previously described. 7 The fusion protein was cleaved using thrombin. The purified HSF-1 protein was activated by heating to 45°C for 30 min prior to use in the in vitro kinase assay.
In-gel kinase assay RAW 264.7 cells were lysed in kinase lysis buffer as described in the in vitro kinase assay and separated on a 10% SDS-PAGE gel containing 0.2 mg/ml of myelin basic protein (Sigma) that was added prior to gel polymerization. After electrophoresis, SDS was removed by incubating the gel for 1 h in 20% isopropanol in 50 mM Tris-HCl (pH 8) followed by a wash for 1 h in 50 mM Tris-HCl (pH 8) containing 1 mM DTT. Proteins were denatured by incubating the gel in 50 mM Tris-HCl (pH 8) containing 6 M guanidine-HCl, 20 mM DTT, and 2 mM EDTA for 1 h and then renatured by incubating overnight at 4°C in 50 mM Tris-HCl (pH 8) containing 1 mM DTT, 2 mM EDTA and 0.04% Tween 20. For the kinase assay, the gels were equilibrated for 1 h in kinase assay buffer containing 40 mM HEPES (pH 8.0), 1 mM DTT, 20 mM MgCl 2 , 0.1 mM EGTA, and 100 µM sodium vanadate. The kinase reaction was performed in the same buffer containing 30 µM ATP and 10 µCi/ml of [γ-32 P]-ATP for 1 h followed by 3-5 washes in 5% trichloroacetic acid containing 1% sodium pyrophosphate. The gels were dried and exposed.
Measurement of TNF-α secretion
RAW 264.7 cells were transferred to 24-well culture plates (2 x 10 5 cells/well) 24 h before stimulation with LPS. Cells were pre-incubated at 39.5°C for 30 min and then stimulated with 100 ng/ml LPS. Calyculin A was added to the cells 30 min before pre-incubation at 39.5°C. Culture supernatant was removed 6 h after LPS addition and TNFα concentration in culture supernatants was measured by ELISA using paired antibodies and a recombinant mouse TNF-α standard from Endogen (Cambridge, MA, USA) in the Cytokine Core Laboratory at the University of Maryland as previously described. 6 TNF-α reporter construct RAW 264.7 cells were co-transfected with a luciferase reporter controlled by a 1.1 kb 5′-flanking sequence fragment from the murine TNF-α gene, pTNF -1080/+138 7 and the blasticidin resistance plasmid, pcDNA6/TR using Fugene-6™ according to the manufacturer's protocol. Stable transfectants were selected using 4 µg/ml of blastocystin. Pooled stable transfectants were analyzed for LPS inducibility and response to FRT and calyculin A treatment by pretreating with calyculin A for 1 h at 37°C, pre-incubating at 37°C or 39.5°C for 30 min, stimulating with 1 µg/ml LPS for 4 h, lysing in cell lysis buffer (Promega), and measuring luciferase activity using a luciferase assay kit (Promega) according to the manufacturer's instructions.
Statistical analysis
Data are presented as mean ± SE. Differences between two groups of data were analyzed using the unpaired Student's t-test. Differences among > 2 groups were tested by applying the Fisher PLSD test applied to a oneway analysis of variance.
RESULTS
We have previously shown that RAW 264.7 macrophages incubated at 39.5°C for 30 min accumulate an intranuclear pool of active HSF-1 that binds to the HRE in the human HSP70 promoter and the putative HSF-1dependent repressor element in the murine TNF-α 5′-UTR, but does not activate the human HSP70 promoter. 6 As we previously reported, LPS induces comparable rates of TNF-α mRNA accumulation in RAW 264.7 cell cultures prewarmed to 39.5°C and in 37°C cells, but TNF-α mRNA levels began to decline 30 min earlier and returned to baseline 3 h earlier in the warmer cells (data reproduced, with permission, in Fig. 1A ). 6 Since we showed that HSF-1 was activated by 30 min exposure to 39.5°C and that activated HSF-1 represses TNFα transcription, 6 this raised the question of how TNF-α expression can occur at all in its presence. To test the hypothesis that LPS treatment reduces levels of activated HSF-1 in prewarmed macrophages, we incubated RAW 264.7 cells at 39.5°C for 30 min to establish a pool of activated HSF-1, then stimulated the warmed cells with 100 ng/ml LPS. As we previously showed using nuclear run-on analysis, LPS induces similar induction of TNF-α transcription in 37°C and 39.5°C RAW 264.7 cell cultures, but transcriptional activation ends 1-3 h earlier in the warmer cells (data reproduced, with permission, in Fig. 1B) . 6 EMSA analysis of nuclear extracts from 39.5°C RAW 264.7 cell cultures using a consensus HRE from the human HSP70 promoter as probe revealed a remarkable temporal correlation between loss of activated HSF-1 and TNF-α transcriptional activation following LPS treatment (Fig. 1C, compare lanes 6-9) . Activated HSF-1 was undetectable 10 min after LPS stimulation co-inciding with peak TNF-α transcription rate, but re-appeared 15-45 min later co-incident with a decrease of the TNF-α transcription rate to basal levels. The DNA-protein complexes that were resolved using cell lysates before and 60 min after LPS stimulation were each supershifted by anti-HSF-1 antibody (Fig. 1E, compare  lanes 2 and 6) . Moreover, formation of HSF-1-DNA complexes in the post-LPS cell lysates were attenuated by addition of an unlabeled oligonucleotide comprising the murine TNF-α 5′-URE sequence containing its putative HRE (Fig. 1E, lane 4) , but not by a sequence containing a mutated HRE (Fig. 1E, lane 5) , a pattern that we have previously shown for HSF-1 in 39.5°C RAW 264.7 cells prior to LPS stimulation. 7 Immunoblot analysis failed to detect an associated change in total cellular HSF-1 protein levels following LPS stimulation (Fig. 1D ), suggesting that HSF-1 was transiently inactivated rather than degraded following LPS treatment. To further evaluate whether HSF-1 is post-translationally modified following LPS stimulation, cell lysates from RAW 264.7 cells prewarmed to 39.5°C for 30 min, then incubated with or without LPS for 15 min were analyzed by 2-dimensional gel electrophoresis and HSF-1 immunoblotting (Fig. 2) . In the absence of LPS, HSF-1 appeared as a single moiety with molecular weight 80 kDa and pI 5.2. Following LPS stimulation, the intensity of the original HSF-1 spot was diminished and two additional spots with similar molecular weight, but with pIs that were 0.3 and 0.6 units lower, respectively, compared with the original HSF-1 spot.
As mentioned earlier, the activation/de-activation of HSF-1 is dependent, in part, on the phosphorylation status of HSF-1. The slight change in electrophoretic mobility of HSF-1 following LPS treatment of RAW 264.7 cells and the appearance of two distinct forms with lower pI is consistent with its limited phosphorylation. LPS is known to activate several serine/threonine kinases, some of which are capable of phosphorylating and deactivating HSF-1. [16] [17] [18] [19] [20] [21] However, the influence of FRT on LPS-stimulated signaling has not been previously reported. To determine whether LPS activates serine/threonine kinases in macrophages that are exposed to FRT, we compared serine/threonine kinase activation in lysates from LPS-treated, 37°C and 39.5°C RAW 264.7 cells using an in-gel kinase assay with myelin basic protein as substrate (Fig. 3 ). This analysis showed several kinase bands, including prominent bands of approximate 40 kDa and 80 kDa molecular weight (indicated by arrows), that were similarly activated by LPS in 37°C and 39.5°C cell cultures (Fig. 3, compare lanes 2 and 3  with 7 and 8 ). This analysis suggests that macrophages are capable of responding to LPS by activating serine/threonine kinases during exposure to FRT.
We further extended our study to determine if one or more of the kinases that are active in LPS-stimulated RAW 264.7 cells at 39.5°C are capable of phosphorylating HSF-1. Using cell extracts from LPS-stimulated RAW 264.7 cells exposed to 39.5°C, we performed an in vitro kinase assay with pre-activated HSF-1 as substrate ( Fig. 4) . Within 15 min of adding LPS to the 39.5°C RAW 264.7 cell cultures, HSF-1 phosphorylating activ-Bacterial endotoxin modifies heat shock factor-1 activity in RAW 264.7 cells 179 ity increased markedly above basal levels and remained elevated 60 min after LPS stimulation (Fig. 4, lanes 4  and 6) . The persistence of the in vitro HSF-1 phosphorylating activity, despite the apparent reversal of HSF-1 inactivation to an active DNA-binding state by 60 min (see Fig. 1C , lane 9) suggests that subsequent up-regulation of a critical serine/threonine phosphatase rather than inactivation of the kinase or kinases that phosphorylate HSF-1, might underlie the transient nature of HSF-1 phosphorylation in the LPS treated cells. Based on these data and the known contribution of serine phosphorylation to HSF-1 regulation, we reasoned that hyperphosphorylation of HSF-1 by LPS-activated kinases might inactivate its DNA binding and TNF-α transcriptional repressor activities. Furthermore, this process was reversible over 30-60 min, suggesting a role for dephosphorylation by a serine/threonine phosphatase in the reactivation of HSF-1 and restoration of TNF-α repression. Therefore, we reasoned that blocking HSF-1 dephosphorylation would abrogate the inhibitory effect of FRT on TNF-α expression.
To test this possibility, we analyzed the effects of the serine/threonine phosphatase inhibitor calyculin A on secretion of TNF-α ( Fig. 5A ) in RAW 264.7 cells warmed to 39.5°C and stimulated with LPS. As we have previously reported in the same cell line, 6, 9 LPS stimulation caused a marked increased in TNF-α release at 37°C that was reduced by 60% in cells incubated at 39.5°C. Pretreating the cells with calyculin A enhanced LPSinduced TNF-α release and, at 3 nM and 5 nM, calyculin A abrogated the difference between TNF-α release at 37°C and 39.5°C. Calyculin A exerted a similar effect on (lanes 2, 3, 7, 8) or medium alone for the indicated time. Cell lysates were analyzed for serine/threonine kinase activity by in gel kinase assay using myelin basic protein as substrate. Following separation on 10% SDS-PAGE containing 0.2 mg/ml myelin basic protein, the gel was subjected to denaturing and renaturing conditions, incubated with [γ-32 P]-ATP, washed, dried and exposed to X-ray film. A representative of three autoradiographs is shown. Fig. 4 . In vitro kinase assay demonstrates that LPS activates HSF-1 phosphorylating activity in 39.5°C RAW 264.7 cell culture. RAW 264.7 cells were pre-incubated at 39.5°C for 30 min (time 0), then stimulated with 100 ng/ml LPS for the indicated time. Cell lysates were analyzed for HSF-1 phosphorylating activity by in vitro kinase assay using preactivated recombinant HSF1 as substrate. The reaction mixture was separated on 10% SDS-PAGE, the gel dried and exposed to X-ray film. Unstimulated 37°C control cell lysates are shown in lane 1. A representative of three experiments is shown. activity of a TNF-α reporter construct (Fig. 5B) . In RAW 264.7 cells stably transfected with a luciferase reporter controlled by a 1.1 kb TNF-α 5′-flanking sequence, treatment with 1 µg/ml LPS for 4 h increased luciferase activity at 37°C 23-fold. Incubating LPS-stimu-lated cells at 39.5°C reduced TNF-α reporter gene activity by 30%. However, in the presence of 3 nM calyculin A, TNF-α reporter gene activity was reduced by only 13% in the 39.5°C cell cultures. Finally, 3 nM calyculin A prevented the re-activation of HSF-1 to a DNA binding form that occurs 30-60 min post-LPS stimulation in its absence (Fig. 5C; compare lanes 4 and 7 in the right panel) . Calyculin A at the doses used caused little or no reduction in viability as assessed the MTS reduction assay (Table 1) , excluding non-specific cytotoxicity as the cause for the loss of FRH effects. Thus calyculin A, a serine/threonine phosphatase inhibitor, abrogates the inhibitory effects of FRT on TNF-α expression while blocking the re-activation of HSF-1 to a DNA binding form following LPS stimulation.
DISCUSSION
We have previously reported that exposing macrophages to FRT temporally restricts LPS-induced TNF-α transcription and alternatively activates HSF-1 to a form that Bacterial endotoxin modifies heat shock factor-1 activity in RAW 264.7 cells 181 Fig. 5 . Calyculin A blocks re-activation of HSF1 DNA binding activity and FRT-induced TNF-α inhibition. (A) RAW 264.7 cells were pretreated with 0-10 nM calyculin A for 1 h, pre-incubated to 37°C or 39.5°C for 30 min, treated with 1 µg/ml LPS for 6 h and TNF-α concentration in culture supernatants were measured by ELISA. Mean ± SE of 4 independent experiments; *denotes P < 0.05 versus 37°C. (B) RAW 264.7 cells, stably transfected with a TNF-α reporter gene were pretreated with 0-3 nM calyculin A for 1 h, pre-incubated at 37°C or 39.5°C for 30 min, treated with 1 µg/ml LPS for 4 h, lysed, and luciferase activity was measured. Mean ± SE of three independent experiments; * and † denote P < 0.001 and P < 0.02 versus 37°C. (C) RAW 264.7 cells were pretreated with 3 nM calyculin A for 1 h, prewarmed to 39.5°C for 30 min, treated with 100 ng/ml LPS and activated HSF was measured by EMSA using the HRE from the human HSP70 promoter. The heat-inducible HSF band is indicated by the arrow. A representative of four similar EMSA experiments is shown. binds to both the HSP70 and TNF-α promoter, but lacks transactivating function. 6 We also showed that transient overexpression of HSF-1 represses a reporter plasmid driven by the murine TNF-α promoter. 6 In this study, we have extended this work by showing that stimulating 39.5°C RAW 264.7 macrophage cultures with LPS causes a transient loss of HSF-1 DNA binding activity that coincides with TNF-α transcriptional activation. We provide evidence that stimulating macrophages with LPS activates one or more kinases that transiently phosphorylate HSF-1, that calyculin A-sensitive serine/threonine phosphatase(s) might reverse this phosphorylation, and that this phosphorylation-dephosphorylation cycle parallels the activation and deactivation of HSF-1 DNA binding activity. In RAW 264.7 cells warmed to 39.5°C and stimulated with LPS, EMSA analysis revealed the loss of activated HSF-1 and its subsequent return in the face of constant levels of immunoreactive HSF-1 protein. Such a discordance suggests that the observed changes in levels of HRE-binding HSF-1 activity were caused by post-translational modification of existing HSF-1 rather than targeted HSF-1 degradation and resynthesis. HSF-1 activity is regulated, in part, by phosphorylation on serine residues [16] [17] [18] [19] 22 and non-covalent association with multiprotein complexes. [23] [24] [25] We found that LPS stimulated a transient small decrease in the electrophoretic mobility of the HSF-1 (Fig. 1D , compare lanes 7 with adjacent lanes) in 39.5°C RAW 264.7 cells, that coincided with the loss of DNA binding activity and suggested an LPS-induced transient covalent modification of HSF-1 might cause its temporary loss of DNA binding and repressor activities. The appearance of two additional HSF-1 moieties with similar molecular weights, but slightly lower pIs, following macrophage stimulation with LPS is consistent with its phosphorylation. The role of phosphorylation in activating HSF-1 is complex. HSF-1 contains 60 serines, many of which are known to be substrates for multiple kinases and each of which has a different functional consequence upon phosphorylation. HSF-1 can be phosphorylated at serine residues by MAP kinases of the ERK family, 16 by protein kinases C (PKC)-α and ζ, 17 and by glycogen synthase kinase 3 (GSK)-α 16,17all of which inhibit its transcriptional activity. Phosphorylation of HSF-1 by c-Jun NH 2 -terminal kinase (JNK) has been shown to either inhibit or activate its transcriptional activity, depending on the physiological context. 18, [26] [27] [28] Several studies also demonstrate the potential role of protein phosphatases in regulating HSF-1 function and the heat shock response. For example, Mevechi et al. 29 reported that okadaic acid, a serine/threonine phosphatase inhibitor, increased HSF-1 activation in Chinese hamster HA-1 cells, as measured by EMSA, and HSP synthesis following heat shock. On the other hand, calyculin A, another serine/threonine phosphatase inhibitor, caused HSF-1 to remain hyperphosphorylated following heat shock, reduced its HRE-binding affinity, and suppressed HSP70 expression in mouse embryonic fibroblasts. 30 In agreement with the latter study, we found that calyculin A prevented return of HSF-1 to an HRE-binding form after LPS stimulation. Collectively, these data show that multiple signaling pathways comprising kinases and phosphatases converge on HSF-1. The net effect of these phosphorylation/dephosphorylation events determines the biological activity of HSF-1. It should be noted that, in the present study, we have demonstrated a loss of HSF-1 DNA binding activity during TNF-α transcriptional activation, but have only inferred a reversal of TNF-α transcriptional repression. It is possible that the loss of HSF-1:DNA binding following macrophage exposure to LPS may not directly cause the loss of TNF-α transcriptional repression.
LPS signals through Toll-like receptor (TLR)-4, 31,32 one of a family of highly conserved type I transmembrane pattern recognition receptors, each of which responds to a distinct set of pathogen associated molecular patterns. 33 These receptors share a common bifurcating signaling pathway leading to activation of NF-κB and all three MAP kinases families. 33 Stimulation of TLR-4 also activates the lipid kinase phosphoinositide-3-kinase (PI3K) and PI3K-dependent kinase-1 (PDK-1). 34 PDK-1 directly activates Akt, which leads to activation of glycogen synthase kinase 3 (GSK)-α and ribosomal S6 kinase (RSK)-1 and 2, 35 as well as PKC-ζ. 36 Jnk, 26, 27 Erk, 16 p38, 37 PKC-α and PKC-ζ, 16 and glycogen synthase kinase 3 (GSK)-α, 16 MAPKAPK-2 38 and RSK-2 38 have each been shown to phosphorylate HSF-1. Furthermore, phosphorylation of HSF-1 by MAPKAPK-2 38 and RSK-2 38 have been shown to inactivate its DNA binding activity. In the present study, an in-gel kinase assay revealed that LPS induced similar patterns of serine/threonine kinase activation at 37°C and 39.5°C. Of particular note, prominent kinase activity bands of approximately 40 kDa and 80 kDa were induced by LPS at both temperatures, suggesting several candidates for an LPS-induced HSF-1-inactivating kinase. The 40 kDa band has an apparent molecular weight similar to that of ERK1/2. The 80 kDa band, a molecular weight similar to those of PKC-α, PKC-ε, RSK-1 and RSK-2.
In this study, we showed that exposing 39.5°C RAW 264.7 cells to LPS induces the activation of kinases capable of phosphorylating HSF-1, and that activation of kinase activity paralleled apparent HSF-1 phosphorylation and inactivation in vivo. We also showed that the serine/threonine phosphatase inhibitor, calyculin A, prevents the repressive effect of FRT, suggesting that subsequent dephosphorylation of HSF-1 by a serine/threonine phosphatase may temporally limit its inactivation after exposure to LPS. Interestingly, HSF-1 is dephosphorylated and re-activated 30-60 min after LPS stimulation, in the face of persistent HSF-1 phosphorylating activity as detected by an in vitro kinase assay. This pattern of events suggests that the HSF-1 inactivation/re-activation cycle might be regulated by sequential activation of a kinase and phosphatase, rather than transient kinase activation in the setting of constitutive phosphatase activity. However, the in vitro kinase assay is not able to distinguish among kinases or phosphorylation sites within HSF-1. It is also possible that delayed activation of additional kinases obscure the activation/de-activation of the kinase that is critical to HSF-1 DNA binding and repressor activities.
Based on these data, we propose the following model to explain the observed truncation of TNF-α expression in macrophages exposed to FRT (Fig. 6 ). Exposure to FRT activates HSF-1 to a transcriptional repressor. Subsequent exposure to LPS triggers a series of signaling pathways, which activate the TNF-α transcriptional machinery, while stimulating the sequential phosphorylation and dephosphorylation of critical serine residues on HSF-1. The phosphorylation and dephosphorylation transiently reverses HSF-1-mediated repression, thus allowing a temporally restricted TNF-α transcription. This model would explain the capacity of calyculin A to restore TNF-α expression in 39.5°C RAW 264.7 cell cultures to those of 37°C cell cultures. In the presence of calyculin A, HSF-1 would be de-activated, but not re-activated, which could produce the same pattern of TNF-α expression as if HSF-1 were never activated at all. However, it is also possible that calyculin A reverses HSF-1 inactivation by modifying upstream signaling pathways. While we have shown that HSF-1 phosphorylation and subsequent dephosphorylation parallels its loss and subsequent reconstitution of DNA binding activity, we have not yet proven that a specific phosphorylation event is responsible for the loss of DNA binding activity. Definitive proof of a link between phosphorylation and dephosphorylation of HSF-1 and its DNA binding and repressor activity await the identification of the phosphorylation site(s) and the analysis of HSF-1 mutants in which each site has been eliminated.
CONCLUSIONS
We have provided evidence that LPS-induced signaling pathways cause post-translational modification of HSF-1 that may explain the change in TNF-α expression pattern to shorter bursts rather than sustained TNF-α synthesis. Such a change in cytokine expression pattern might retain the immunostimulatory activity of TNF-α while reducing the risk of host tissue injury that can be caused by sustained exposure to high levels of TNF-α. 39 Fig. 6 . Hypothetical model of HSF-1 the phosphorylation/dephosphorylation cycle that is activated by LPS stimulation of macrophages and which limits the duration of TNF-α transcription. HSF-1 is activated by FRH to an alternatively activated repressor form that can bind DNA, repress TNF-α transcription, but which does not trans-activate heat shock protein genes. Macrophage activation by LPS causes HSF-1 to be inactivated through a phosphorylation event, which is subsequently reverse through the actions of a phosphatase. The period during which HSF-1 is inactive provides a defined window for TNF-α expression.
